ClinConnect ClinConnect Logo
Search / Trial NCT03300713

MOther-Child Interaction Assessment TRAINING for Pediatricians

Launched by UNIVERSITY HOSPITAL, LILLE · Sep 28, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Mass Screening Pediatrician Training

ClinConnect Summary

The MOCITRAINING study is looking at how pediatricians can better support the relationship between mothers and their babies, especially during the first month after birth. The goal is to see if teaching doctors to focus on both the mother and child together during visits can improve their interactions and overall well-being in the short and medium term. This study is important because strong mother-child relationships are crucial for the child’s development and can help address issues like child behavior disorders and maternal depression.

To participate in this study, mothers and their one-month-old (plus or minus 15 days) biological children can join, but mothers need to be able to read French and provide consent after being fully informed about the study. Unfortunately, preterm babies, twins, or those with certain medical conditions won’t be eligible. If you join the study, you can expect to take part in a program designed to enhance your interactions with your child, and you’ll have the support of healthcare professionals throughout the process.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Each child will be included WITH his biological mother at the first-month visit after birth.
  • Age: 1 month + / - 15 days (child), accompanied by his biological mother
  • Mother able to read French;
  • Signed consent letter after complete information of parents about the MOCITRAINING study, its principle, advantages and disadvantages.
  • Exclusion Criteria:
  • Preterm babies.
  • Children from a twin or multiple pregnancy.
  • Children with somatic diagnosis explaining the presence of digestive, sleeping or interactional disorders.
  • Refusal to participate after clear information about the study;
  • Refusal to sign the consent letter;
  • Refusal to be informed of a diagnostic hypothesis;
  • Participants not covered by the Social Security system;
  • Participants incapable of consenting or under legal protection (guardianship or curatorship).

About University Hospital, Lille

University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.

Locations

Lille, , France

Patients applied

0 patients applied

Trial Officials

Renaud Jardri, MD, PhD

Principal Investigator

University Hospital, Lille

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials